Indeed, comparing PrPC and the PK-resistant PrPSc (PrPres) by western blotting has clearly disclosed that all variably glycosylated PrPC species are able to convert into PrPres in virtually all typical human prion diseases. This evidence concerns the gene PRNP and prion disease.